In contrast, sales revenues from Anti-malarial drugs are forecast to decline from Ush100.9 billion ($27 million) in 2024 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback